Ortho Development Corporation received FDA 510(k) clearance for its Trivicta hip system, which utilizes a triple-taper stem for stability in total hip arthroplasty. The system will be available in the US in the second quarter of 2024. The company’s president and CEO, Brent Bartholomew, highlighted Trivicta’s versatility in addressing a range of patient needs and…
The United Kingdom has released detailed data on clinical trial registrations, making it the first country to do so. The Health Research Authority shared information on 1,545 trials, showing a 92% registration rate in 2022, an improvement from previous years. Most trials were registered on ClinicalTrials.gov, a U.S. database. This move was applauded by transparency…
A study presented at the European Congress of Clinical Microbiology and Infectious Diseases found an association between tuberculosis (TB) infection and an increased risk of various cancers. The study, conducted in South Korea, revealed that TB patients had a significantly higher incidence of cancer compared to the general population, including lung, blood, gynecological, colorectal, thyroid,…
Social media use among patients considering or undergoing plastic and reconstructive surgery (PRS) procedures can enhance patient empowerment, leading to increased autonomy and better decision-making. A study found that patients seeking information online had higher empowerment scores, especially on social media platforms like Facebook and RealSelf. Plastic surgeons are encouraged to engage and contribute to…
Teenagers are experts at manipulating their parents to get what they want, avoid trouble, or feel powerful. Experts suggest countering this manipulation with tactics such as setting boundaries, enforcing consequences, and being consistent. Parents should establish rules and stick to them, even in the face of emotional blackmail or sulking. By setting limits on activities,…
Bristol Myers Squibb’s experimental drug for Crohn’s disease, ozanimod, did not help patients achieve disease remission in a late-stage study. Crohn’s is a chronic bowel disease causing inflammation in the digestive tract, leading to symptoms like diarrhea, abdominal pain, and fatigue. The drug, acquired through a buyout of Celgene, did not result in a significant…
A recent study has found that Deucravacitinib can improve outcomes in patients with psoriatic arthritis. The drug showed promising results in reducing symptoms and improving quality of life for individuals with this condition. The study highlights the potential benefits of Deucravacitinib as a treatment option for psoriatic arthritis. By continuing to use the site, you…
Akebia Therapeutics’ drug, Vafseo, has received FDA approval for treating anemia in adults with chronic kidney disease. The drug, vadadustat, is an oral medication that mimics the effects of high altitude to stimulate the production of erythropoietin, a hormone that regulates red blood cell production. Despite safety concerns, including a black box warning for cardiovascular…
Irish researchers have found a promising new treatment combination for multiple myeloma, a difficult-to-treat cancer. They discovered that combining the drug venetolax with 5-azacytidine significantly increased its effectiveness across many cancer cell lines, offering potential benefits for a broader patient population. The research, led by the RCSI Department of Physiology and Medical Physics, also showed…
Google has changed its search algorithm to show a broader range of results for keywords, potentially affecting the precision of pay-per-click advertising campaigns for ophthalmologists. This could lead to lower return on investment as ads for unrelated services may show up in search results. Cynthia A. Matossian, MD, FACS, and David Evans, PhD, MBA, discuss…
